Elderly patients with non-Hodgkin lymphoma who receive chemotherapy are at higher risk for osteoporosis and fractures

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Leukemia and Lymphoma

• Publication date

  2007-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/10428190701471973PMID 17701582
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Non-Hodgkin lymphoma: diagnosis and treatment.

  2015cited by this paper
• Falls and Gait Characteristics Among Older Persons with Peripheral Neuropathy

  2007cited by this paper
• The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis.

  2006cited by this paper
• Osteoimmunology: interplay between the immune system and bone metabolism.

  2006cited by this paper
• The Pathogenesis, Epidemiology and Management of Glucocorticoid-Induced Osteoporosis

  2006cited by this paper
• Effect of Chemotherapy on Skeletal Health in Male Survivors from Testicular Cancer and Lymphoma

  2006cited by this paper
• Effect of an Aromatase Inhibitor on BMD and Bone Turnover Markers: 2‐Year Results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) Trial (18233230)

  2006cited by this paper
• Respective contributions of vertebroplasty and kyphoplasty to the management of osteoporotic vertebral fractures.

  2006cited by this paper
• External Validation of Medicare Claims for Breast Cancer Chemotherapy Compared With Medical Chart Reviews

  2006cited by this paper
• Osteoporosis: a still increasing prevalence.

  2005cited by this paper
• Quality-of-life issues in osteoporosis

  2005cited by this paper
• Variation in modes of chemotherapy administration for breast carcinoma and association with hospitalization for chemotherapy‐related toxicity

  2005cited by this paper
• Fracture risk in patients with prostate cancer on androgen deprivation therapy

  2005cited by this paper
• Increased risk of falls and increased bone resorption in elderly men with partial androgen deficiency: the MINOS study.

  2003cited by this paper
• Rituximab as first-line and maintenance therapy for patients with indolent non-hodgkin's lymphoma.

  2002cited by this paper
• Epidemiology and outcomes of osteoporotic fractures.

  2002cited by this paper
• Overview of the SEER-Medicare Data: Content, Research Applications, and Generalizability to the United States Elderly Population

  2002cited by this paper
• Studying Radiation Therapy Using SEER-Medicare-Linked Data

  2002cited by this paper
• Utility of the SEER-Medicare Data to Identify Chemotherapy Use

  2002cited by this paper
• Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonists.

  2001cited by this paper
• Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data.

  2001cited by this paper
• Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation.

  2001cited by this paper
• Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer.

  2001cited by this paper
• Andropause.

  2000cited by this paper
• Recognition of Vertebral Fracture in a Clinical Setting

  2000cited by this paper
• Development of a comorbidity index using physician claims data.

  2000cited by this paper
• Information on radiation treatment in patients with breast cancer: the advantages of the linked medicare and SEER data. Surveillance, Epidemiology and End Results.

  1999cited by this paper
• Risk Factors for Major Injurious Falls among the Home-Dwelling Elderly by Functional Abilities

  1998cited by this paper
• Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy.

  1998cited by this paper
• The crippling consequences of fractures and their impact on quality of life.

  1997cited by this paper
• Inhaled and oral corticosteroids: their effects on bone mineral density in older adults.

  1995cited by this paper
• Categorical Data Analysis Using The SAS1 System

  1995cited by this paper
• Completeness of hospital cancer case reporting from the SEER program of the national cancer institute

  1995cited by this paper
• Peripheral neuropathy: a true risk factor for falls.

  1995cited by this paper
• Reduced bone mineral density in men following chemotherapy for Hodgkin's disease.

  1994cited by this paper
• Potential for Cancer Related Health Services Research Using a Linked Medicare‐Tumor Registry Database

  1993cited by this paper
• Bone mineralization in women following successful treatment of Hodgkin's disease.

  1988cited by this paper
• Reduction of serum testosterone levels during chronic glucocorticoid therapy.

  1986cited by this paper

• Increased risk of hip and other major osteoporotic fractures within 18 months of lymphoma diagnosis—a national registry study of 36,864 Swedish lymphoma patients

  2025cites this paper
• Beyond bone: the emerging role of osteoclasts in immune regulation, leukemia development and following myeloablative therapy.

  2025cites this paper
• Opportunistic bone density assessment using pretreatment [18F]FDG-PET/CT identifies fracture risk in lymphoma patients undergoing corticosteroid-containing chemotherapy

  2025cites this paper
• Bone damage and health-related quality of life in Hodgkin lymphoma survivors: closing the gaps

  2024cites this paper
• Risk of fractures and use of bisphosphonates in adult patients with immune thrombocytopenia—A nationwide population‐based study

  2024cites this paper
• Osteoporosis Etiology, Epidemiology, Diagnosis, Diet, and Treatment: A Narrative Review

  2024cites this paper
• Fracture risk among patients with cancer compared to individuals without cancer: a population-based study

  2023cites this paper
• Body Composition in Patients with Follicular Lymphoma: Asso-Ciations between Changes in Radiomic Parameters in Patients Treated with R-CHOP-like and R-B Regimens: LyRa 01F

  2023cites this paper
• CT-based body composition in diffuse large B cell lymphoma patients: changes after treatment and association with survival

  2023cites this paper
• Late Endocrine and Metabolic Sequelae and Long-Term Monitoring of Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi

  2022cites this paper
• A randomized trial of alendronate as prophylaxis against loss in bone mineral density following lymphoma treatment

  2022cites this paper
• Bone health and glucocorticoid‐containing lymphoma therapy — a review of risk factors and preventative measures

  2022cites this paper
• Secondary Osteoporosis and Metabolic Bone Diseases

  2022cites this paper
• Significant reduced loss of bone mineral density after four vs. six cycles of R-CHOP: an analysis of the FLYER-trial

  2021cites this paper
• High incidence of fractures after R-CHOP-like chemotherapy for aggressive B-cell non-Hodgkin lymphomas

  2021cites this paper
• Blood and Bone Epidemiological studies on the association between blood and bone

  2021cites this paper
• Identification of non-Hodgkin lymphoma patients at risk for treatment-related vertebral density loss and fractures

  2020cites this paper
• Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphoma.

  2020cites this paper
• Increased Risk of Hip Fracture in Patients with Lymphoma, a Swedish Population Study of 37,236 Lymphoma Patients

  2020cites this paper
• Radiographic Study of Lamina Dura in Patients on Corticosteroids

  2020cites this paper
• Low Bone Mineral Density and High Bone Turnover in Patients With Non-Hodgkin's Lymphoma (NHL) Who Receive Frontline Therapy: Results of a Multicenter Prospective Study

  2019cites this paper
• Molecular imaging of bone metastases using bone targeted tracers.

  2019cites this paper
• Bone Disorders in Cancer

  2017cites this paper
• R-CHOP(-like) treatment of diffuse large B-cell lymphoma significantly reduces CT-assessed vertebral bone density: a single center study of 111 patients

  2017cites this paper
• Primary and secondary bone lymphomas.

  2015cites this paper
• Fungal immunomodulatory proteins alleviate docetaxel-induced adverse effects

  2015cites this paper
• Self-reported endocrine late effects in adults treated for brain tumours, Hodgkin and non-Hodgkin lymphoma: a registry based study in Northern Germany.

  2015cites this paper
• Alterations in bone mineral density and bone turnover markers in newly diagnosed adults with lymphoma receiving chemotherapy: a 1-year prospective pilot study.

  2014cites this paper
• The clinical features, management and prognostic effects of pathological fractures in a multicenter series of 373 patients with diffuse large B-cell lymphoma of the bone.

  2014cites this paper
• Bone mineral density screening should be routine in lymphoma patients.

  2014cites this paper
• Incident comorbidities and all-cause mortality among 5-year survivors of Stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study

  2014cites this paper
• A checklist for ascertaining study cohorts in oncology health services research using secondary data: report of the ISPOR oncology good outcomes research practices working group.

  2013cites this paper
• Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trial.

  2013cites this paper
• Impact of denosumab on bone mass in cancer patients

  2013cites this paper
• Osteoporosis related to disease or therapy in patients with cancer.

  2011cites this paper
• MINI-SENTINEL SYSTEMATIC EVALUATION OF HEALTH OUTCOME OF INTEREST DEFINITIONS FOR STUDIES USING ADMINISTRATIVE DATA LYMPHOMA REPORT

  2011cites this paper
• Bone complications of cancer treatment in the elderly.

  2010cites this paper
• Cancer Therapies and Bone Health

  2010cites this paper
• Chemotherapy for the Older Adult with Cancer

  2009cites this paper
• Risk of Dementia in Older Breast Cancer Survivors: A Population‐Based Cohort Study of the Association with Adjuvant Chemotherapy

  2009cites this paper
• Current awareness: Pharmacoepidemiology and drug safety

  2008cites this paper
• Immunotherapy and radioimmunotherapy for non- Hodgkin's Lymphoma

  2008cites this paper
• Incidence and prevalence of medication-induced osteoporosis: evidence-based review

  2008cites this paper